Surmodics | SRDX - Operating Expenses


Surmodics reported $29.51M in Operating Expenses for its fiscal quarter ending in June of 2025.





Operating Expenses Change Date
Abbott USD 9.21B 17M Dec/2025
Align Technology USD 822.85M 11.8M Dec/2025
Anika Therapeutics USD 29.97M 116.84M Dec/2025
Arrowhead Research USD 223.22M 10.86M Dec/2025
Artivion USD 111.2M 9.45M Dec/2025
Baxter International USD 3.19B 554.4M Dec/2025
Boston Scientific USD 4.04B 18M Dec/2025
EDAP TMS EUR 18.8M 3.01M Sep/2025
Edwards Lifesciences USD 1.2B 71.3M Dec/2025
Haemonetics USD 134.99M 1.26M Dec/2025
Heron Therapeutics USD 40.55M 1.46M Dec/2025
J&J USD 17.44B 1.53B Mar/2026
Merit Medical Systems USD 339.74M 1.8M Dec/2025
Mesa Laboratories USD 33.98M 2.03M Dec/2024
Nektar Therapeutics USD 40.9M 44.19M Dec/2025
Option Care Health USD 1.37B 23.44M Dec/2025
Stryker USD 5.2B 505M Dec/2025
Surmodics USD 29.51M 274.86M Jun/2025
Trinity Biotech USD 14.82M 7.81M Sep/2025